David Kneen

David Kneen has a diverse work experience in the biotech and healthcare industry. David co-founded and currently serves as the Chief Executive Officer and Head of Commercial at Celleo Biotech, where they focus on intelligent production systems for Cell & Gene Therapies. Prior to that, they worked at Neo-Bionica in Corporate Development, structuring collaboration deals for neurotech companies. David also served as the Industry Interface Representative at CCRM Australia, and as the Principal at Kneen Advisory. Additionally, David has held positions at CH4Global, Invetech, Fortive, CRC for Cell Therapy Manufacturing, and Deakin University, where they contributed to various roles ranging from COO to Program Manager and Advisory Board Member.

David Kneen attended Melbourne Business School from 2008 to 2010 and earned their MBA with a focus on Finance, Business Strategy, and Innovation Management. In 2009, they also attended HEC Paris for a short period to further their MBA studies. Prior to that, from 1997 to 2002, David Kneen studied at the University of Melbourne, completing a BE/BSc degree in Mechanical Engineering, Applied Mathematics, and Physics. Their educational journey began at Trinity Grammar School, Kew, where they attended from 1991 to 1996. No specific degree or field of study is provided for this period.